These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21312266)
1. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis. Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266 [TBL] [Abstract][Full Text] [Related]
2. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors. Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593 [TBL] [Abstract][Full Text] [Related]
3. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of connective tissue growth factor reduces migration and invasiveness of osteosarcoma cells. Huang Y; Zhao S; Zhang C; Li X Mol Med Rep; 2016 Feb; 13(2):1888-94. PubMed ID: 26707502 [TBL] [Abstract][Full Text] [Related]
6. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. Fromigué O; Hamidouche Z; Marie PJ J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811 [TBL] [Abstract][Full Text] [Related]
7. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma. Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824 [TBL] [Abstract][Full Text] [Related]
9. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice. Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710 [TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848 [TBL] [Abstract][Full Text] [Related]
11. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222 [TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance and malignancy in human osteosarcoma. Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324 [TBL] [Abstract][Full Text] [Related]
13. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61. Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075 [TBL] [Abstract][Full Text] [Related]
14. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647 [TBL] [Abstract][Full Text] [Related]
15. miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma. Xu Y; Chu H; Zhou Y; Wang J; Dong C; Yin R Biomed Pharmacother; 2018 Feb; 98():531-537. PubMed ID: 29287201 [TBL] [Abstract][Full Text] [Related]
16. Annexin 2 expression is reduced in human osteosarcoma metastases. Gillette JM; Chan DC; Nielsen-Preiss SM J Cell Biochem; 2004 Jul; 92(4):820-32. PubMed ID: 15211578 [TBL] [Abstract][Full Text] [Related]
17. [Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer]. Jia WD; Wang W; Tang ZY; Xu GL; Sun HC; Zhou HJ Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):241-5. PubMed ID: 19615273 [TBL] [Abstract][Full Text] [Related]
18. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis. Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269 [TBL] [Abstract][Full Text] [Related]
19. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis. Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]